Bpifrance

SUPERBRANCHE is a biotechnology company focused on the early detection and treatment of metastases using advanced nanotechnology. The company develops therapeutic and diagnostic applications that aim to enhance accessibility and facilitate the timely identification of tumors. Its innovative platform incorporates targeted diagnostic and image-guided therapy nanomaterials, grounded in proprietary technology. This approach enables healthcare providers to detect and address metastases earlier, ultimately improving patient outcomes.

ABIONYX Pharma SA is a French biopharmaceutical company established in 2005, currently based in Labege. It specializes in the discovery and development of therapies targeting high-density lipoprotein (HDL) for treating cardiovascular and metabolic diseases. The company's primary focus is on developing HDL mimetics to rapidly regress atherosclerotic plaque in high-risk patients. Its lead product candidate, CER-001, is a Phase II clinical trial asset designed to mimic the properties of pre-beta HDL for treating post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients. Additionally, ABIONYX Pharma has another drug candidate, CER-209, in Phase I trials for metabolic diseases and liver-related conditions such as atherosclerosis and non-alcoholic steato-hepatitis.

Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, that specializes in the design, development, and production of amorphous metal parts. Founded in 2017, Vulkam utilizes biocompatible amorphous metal alloys primarily composed of materials such as zirconium, copper, hafnium, nickel, and titanium. The company's innovative products find applications across various industries, including aerospace, automotive, biomedical, cryogenic, watches, jewellery, and micro components. Vulkam's focus on creating micromechanical parts that are significantly smaller yet maintain strength and functionality sets a new standard in metallurgy and metal processing, positioning the company as a leader in the development of advanced metal technologies.

Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, that specializes in the design, development, and production of amorphous metal parts. Founded in 2017, Vulkam utilizes biocompatible amorphous metal alloys primarily composed of materials such as zirconium, copper, hafnium, nickel, and titanium. The company's innovative products find applications across various industries, including aerospace, automotive, biomedical, cryogenic, watches, jewellery, and micro components. Vulkam's focus on creating micromechanical parts that are significantly smaller yet maintain strength and functionality sets a new standard in metallurgy and metal processing, positioning the company as a leader in the development of advanced metal technologies.

Novacium operates as an innovative start-up that specializes in the next generation material development.

Quandela is a company specializing in quantum computing, focusing on the development of communication networks and optical computers. It manufactures photonic quantum computers and markets them to industrial clients. The company's flagship product, a single-photon source device, integrates photonics with semiconductor quantum dots, facilitating quantum communication, computation, and sensing. This device allows for the efficient collection of emitted single photons at high rates, helping researchers minimize charge noise decoherence and achieve the emission of identical photons with high fidelity. These advancements are crucial for the progress of sophisticated quantum applications, positioning Quandela as a key player in the field of quantum technology.

Hummink is a Paris-based company founded in 2020 that specializes in additive manufacturing technology focused on nanoscale design and production. The company utilizes a patented technology that integrates a nanometric pen with an oscillating microresonator to achieve capillary deposition of various liquids. This innovative approach allows clients in the semiconductor and molecular diagnostic industries to create large objects while maintaining high resolution and precision on substrates ranging from millimetric to centimetric scales. Hummink's advancements in nano-printing technology position it as a valuable player in the field of precision manufacturing.

Scintil Photonics SAS, founded in 2018 and based in Grenoble, France, specializes in the development of silicon photonic integrated circuits aimed at advancing high-speed optical communications and chip interconnections. The company offers a range of products, including multi-wavelength lasers, waveguides, wavelength filters, and photodetectors. By employing wafer-scale bonding techniques that combine Silicon and Indium Phosphide materials, Scintil Photonics creates fully integrated circuits that enhance performance and reliability while significantly lowering implementation costs. Their innovative approach allows for the monolithic integration of optical amplifiers and lasers on advanced silicon photonic circuits, making their solutions suitable for a variety of industrial applications.

NAWA Technologies specializes in developing advanced energy storage solutions, focusing on its innovative Ultra Fast Carbon Battery Technology. Founded in April 2013 and supported by over 15 years of research and development in nanomaterials, the company aims to enhance energy conversion, storage, transport, and efficiency using carbon, which is abundant and environmentally friendly. NAWA Technologies creates ultracapacitors and battery electrodes that facilitate the integration of renewable energies into smart grids, thus promoting more efficient and sustainable electricity storage. The company is committed to minimizing the environmental impact of its manufacturing processes and emphasizes the importance of reusing, recovering, and recycling materials throughout the product lifecycle. With a dedicated team of 24 employees, NAWA Technologies operates a pilot production line to innovate new interface materials and storage devices that reduce carbon emissions and reliance on fossil fuels.

Quandela is a company specializing in quantum computing, focusing on the development of communication networks and optical computers. It manufactures photonic quantum computers and markets them to industrial clients. The company's flagship product, a single-photon source device, integrates photonics with semiconductor quantum dots, facilitating quantum communication, computation, and sensing. This device allows for the efficient collection of emitted single photons at high rates, helping researchers minimize charge noise decoherence and achieve the emission of identical photons with high fidelity. These advancements are crucial for the progress of sophisticated quantum applications, positioning Quandela as a key player in the field of quantum technology.

Grapheal is a Medtech startup focused on developing embedded and wearable biosensors that leverage graphene transistors for enhanced functionality. Their devices are designed to be minimalistic and digital, enabling the dosing of biomarkers and detection of pathogens through a smartphone interface. By integrating advanced sensing nanomaterials with wireless connectivity and data analysis capabilities, Grapheal's biosensors facilitate field diagnostics and remote patient monitoring. This approach aims to make healthcare more accessible and accurate, allowing medical professionals to effectively monitor patient progress and healing.

NAWA Technologies specializes in developing advanced energy storage solutions, focusing on its innovative Ultra Fast Carbon Battery Technology. Founded in April 2013 and supported by over 15 years of research and development in nanomaterials, the company aims to enhance energy conversion, storage, transport, and efficiency using carbon, which is abundant and environmentally friendly. NAWA Technologies creates ultracapacitors and battery electrodes that facilitate the integration of renewable energies into smart grids, thus promoting more efficient and sustainable electricity storage. The company is committed to minimizing the environmental impact of its manufacturing processes and emphasizes the importance of reusing, recovering, and recycling materials throughout the product lifecycle. With a dedicated team of 24 employees, NAWA Technologies operates a pilot production line to innovate new interface materials and storage devices that reduce carbon emissions and reliance on fossil fuels.

Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, that specializes in the design, development, and production of amorphous metal parts. Founded in 2017, Vulkam utilizes biocompatible amorphous metal alloys primarily composed of materials such as zirconium, copper, hafnium, nickel, and titanium. The company's innovative products find applications across various industries, including aerospace, automotive, biomedical, cryogenic, watches, jewellery, and micro components. Vulkam's focus on creating micromechanical parts that are significantly smaller yet maintain strength and functionality sets a new standard in metallurgy and metal processing, positioning the company as a leader in the development of advanced metal technologies.

Scintil Photonics SAS, founded in 2018 and based in Grenoble, France, specializes in the development of silicon photonic integrated circuits aimed at advancing high-speed optical communications and chip interconnections. The company offers a range of products, including multi-wavelength lasers, waveguides, wavelength filters, and photodetectors. By employing wafer-scale bonding techniques that combine Silicon and Indium Phosphide materials, Scintil Photonics creates fully integrated circuits that enhance performance and reliability while significantly lowering implementation costs. Their innovative approach allows for the monolithic integration of optical amplifiers and lasers on advanced silicon photonic circuits, making their solutions suitable for a variety of industrial applications.

NH TherAguix SAS is a clinical stage pharmaceutical company based in Villeurbanne, France, focused on developing nanomedicines for cancer treatment, specifically utilizing radiotherapy. The company's lead product, AGuIX, is a theranostic nanoparticle designed to enhance the localization of solid tumors and improve the effectiveness of radiation therapy. AGuIX allows for the determination of optimal irradiation timing and is capable of treating radioresistant cancers while minimizing radiation exposure to healthy tissues, thereby reducing secondary effects. Founded in 2015, NH TherAguix is dedicated to advancing innovative solutions in cancer care through its pioneering research and development efforts.

APIX Analytics, founded in 2014 and headquartered in Grenoble, France, specializes in developing and marketing advanced gas analyzer systems. The company focuses on creating miniaturized multigas analyzers that leverage nano-silicon technology to enhance chemical analysis across industrial, environmental, and security applications. By integrating traditional analytical processes such as gas sampling, injection, and separation of complex mixtures, APIX Analytics improves the specificity, detection, identification, and quantification of gas compounds. This innovative approach aims to support clients in meeting safety and quality standards in various sectors, particularly in renewable development.

Nanobiotix SA is a clinical-stage nanomedicine company based in Paris, France, focused on innovative cancer treatments. Founded in 2003, the company develops NanoXray products designed to enhance the effectiveness of radiotherapy by increasing the impact on tumor cells while minimizing exposure to surrounding healthy tissues. One of its primary offerings is NBTXR3, a radio-enhancer composed of hafnium oxide, which targets various solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, and glioblastoma. In addition to NBTXR3, Nanobiotix is also involved in research programs exploring the use of magnetic particles and laser-activated nanoparticles for cancer treatment and diagnostics.

Nanobiotix SA is a clinical-stage nanomedicine company based in Paris, France, focused on innovative cancer treatments. Founded in 2003, the company develops NanoXray products designed to enhance the effectiveness of radiotherapy by increasing the impact on tumor cells while minimizing exposure to surrounding healthy tissues. One of its primary offerings is NBTXR3, a radio-enhancer composed of hafnium oxide, which targets various solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, and glioblastoma. In addition to NBTXR3, Nanobiotix is also involved in research programs exploring the use of magnetic particles and laser-activated nanoparticles for cancer treatment and diagnostics.

Nanobiotix SA is a clinical-stage nanomedicine company based in Paris, France, focused on innovative cancer treatments. Founded in 2003, the company develops NanoXray products designed to enhance the effectiveness of radiotherapy by increasing the impact on tumor cells while minimizing exposure to surrounding healthy tissues. One of its primary offerings is NBTXR3, a radio-enhancer composed of hafnium oxide, which targets various solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, and glioblastoma. In addition to NBTXR3, Nanobiotix is also involved in research programs exploring the use of magnetic particles and laser-activated nanoparticles for cancer treatment and diagnostics.